Vimarsana
Biggest News Aggregation in the World

Imux News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imux Today - Breaking & Trending Today

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com - Vimarsana News

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com

StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […]

Source: wkrb13.com
Immunic (IMUX) to Release Earnings on Thursday - Vimarsana News

Immunic (IMUX) to Release Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX) - Vimarsana News

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]

Immunic Shares Rise Premarket on Private-Placement Financing - Vimarsana News

Immunic Shares Rise Premarket on Private-Placement Financing

By Colin Kellaher Shares of Immunic rose more than 10% in premarket trading Friday after the biotechnology company said it struck a deal to raise up to $240...

Immunic (NASDAQ:IMUX) PT Raised to $7.00 at Wedbush - Vimarsana News

Immunic (NASDAQ:IMUX) PT Raised to $7.00 at Wedbush

Immunic (NASDAQ:IMUX – Free Report) had its price target lifted by Wedbush from $5.00 to $7.00 in a research note published on Tuesday, MarketBeat Ratings reports. The firm currently has an outperform rating on the stock. Separately, StockNews.com initiated coverage on Immunic in a research note on Thursday, October 5th. They issued a sell rating […]